Business

Earnings show Eli Lilly winning in the GLP-1 market over Novo Nordisk

0 CommentsBusiness

💥 Read this must-read post from Business News 📖 📂 **Category**: 💡 **What You’ll Learn**: Eli Lilly and Novo Nordisk logos.Mike Blake | Tom Little | ReutersIt's the story of two drugmakers in the hot obesity drug market. both of them Novo Nordisk and Eli Lilly Pharmaceutical companies are facing falling prices in the United States, but their forecasts for 2026 vary sharply: While Novo is bracing for a decline in sales, Lilly expects revenues to rise again thanks to its blockbuster drugs. The split in guidance - despite similar headwinds - underscores the strength of Lilly's position in the…

Read More

Corporate DEI Index sees 65% drop in participation compared to Fortune 500

0 CommentsBusiness

💥 Check out this must-read post from Business News 📖 📂 **Category**: 📌 **What You’ll Learn**: People carry flags outside the U.S. Supreme Court on December 4, 2024 in Washington, D.C., during oral argument on whether states can ban certain medical transgender treatments for young people. Roberto Schmidt | AFP | Getty ImagesNew research by the LGBTQ+ Human Rights Campaign shows a sharp decline in Fortune 500 companies willing to publicly disclose their diversity, equity, and inclusion practices.The HRC's 2026 Corporate Equality Index saw a 65% drop in participation this year, falling from 377 Fortune 500 companies in 2025 to…

Read More

Brand Earnings (YUM) Q4 2025

0 CommentsBusiness

🚀 Discover this must-read post from Business News 📖 📂 **Category**: 💡 **What You’ll Learn**: A customer enters a Taco Bell restaurant in El Cerrito, California, US, on Tuesday, April 29, 2025. David Paul Morris | Bloomberg | Getty ImagesYum brands On Wednesday, it reported mixed quarterly results, despite strong demand for Taco Bell.Here's what the company reported for the period ending December 31 compared to what Wall Street was expecting, based on a survey of analysts conducted by LSEG:Earnings per share: $1.73 adjusted versus $1.77 expectedRevenue: $2.51 billion versus $2.45 billion expectedYum reported fourth-quarter net income of $535 million,…

Read More

Here is the breakdown of borrowers in the United States

0 CommentsBusiness

🚀 Discover this must-read post from Business News 📖 📂 **Category**: 💡 **What You’ll Learn**: An aerial view of homes in San Francisco, August 27, 2025.Justin Sullivan | Getty ImagesThe share of U.S. homeowners enjoying high interest rates on their mortgages has jumped sharply in just the past few years. This has a noticeable impact on the refinancing market and a somewhat more subdued impact on home sales. Prices have been front and center in the debate about how to improve home affordability — and for good reason. In 2022, after mortgage interest rates hit more than a dozen record…

Read More

Eli Lilly (LLY) Q4 2025 earnings

0 CommentsBusiness

🚀 Read this trending post from Business News 📖 📂 **Category**: 💡 **What You’ll Learn**: The Eli Lilly and Company logo is displayed during a press conference in Houston, Texas, US, September 23, 2025. Antranik Tavityan | ReutersEli Lilly On Wednesday, it reported fourth-quarter earnings, revenue and 2026 guidance that blew away previous estimates, as demand surged for blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro. The pharmaceutical giant expects its 2026 revenues to range between $80 billion and $83 billion. Analysts expected revenue of $77.62 billion, according to LSEG. Lilly also expects adjusted earnings to range between $33.50…

Read More

Streaming-only Super Bowl ads are gaining traction on NBC’s Peacock channel

0 CommentsBusiness

✨ Explore this insightful post from Business News 📖 📂 **Category**: 📌 **What You’ll Learn**: A Super Bowl LX sign appears at Civic Center Plaza in San Francisco, Friday, January 30, 2026. Steven Lamm | San Francisco Chronicle | Hearst Newspapers | Getty ImagesThe Super Bowl is a major event each year for advertisers eager to get their brands in front of millions of consumers at once. It is also expensive. That's why a small subset of ad space for broadcast-only commercials is gaining traction and giving smaller brands time during the biggest TV night of the year. Comcast Broadcast…

Read More

Chipotle (CMG) Q4 2025 earnings

0 CommentsBusiness

🔥 Explore this trending post from Business News 📖 📂 **Category**: ✅ **What You’ll Learn**: The New York Stock Exchange welcomes Chipotle (NYSE: CMG) executives and guests to the podium, Friday, December 12, 2025, to celebrate the milestone of 4,000 restaurants. To mark the occasion, Scott Boatwright, Chief Executive Officer, joined by Chris Taylor, Chief Development Officer of the New York Stock Exchange, rang the opening bell®.Chipotle Mexican Grill It is expected to report fourth-quarter earnings after the bell on Tuesday.Here's what Wall Street analysts surveyed by LSEG expect the company to announce:EPS: Expected 24 centsprofit: Expected $2.96 billionOver the…

Read More

“Huge” investor demand for residential buildings

0 CommentsBusiness

✨ Check out this trending post from Business News 📖 📂 **Category**: ✅ **What You’ll Learn**: Camden Property Trust CEO Rick Campo.Courtesy of Camden Estate TrustA version of this article first appeared in the CNBC Property Play newsletter with Diana Olek. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. subscription To receive future issues, directly to your inbox.Fundamentals are weakening in the multifamily apartment market as a historic boom in new supply continues to make its way through the pipeline…

Read More

Patriots owner Robert Kraft responds to Hall of Fame controversy

0 CommentsBusiness

🚀 Check out this trending post from Business News 📖 📂 **Category**: ✅ **What You’ll Learn**:

Read More

Merck (MRK) Q4 2025 earnings

0 CommentsBusiness

🚀 Check out this trending post from Business News 📖 📂 **Category**: 💡 **What You’ll Learn**: Merck on Tuesday reported fourth-quarter earnings and revenue that beat estimates due to strong demand for its Keytruda cancer immunotherapy and some newer products. But the company posted a modest forecast for 2026 that fell short of Wall Street expectations as it prepares to lose a few of its drugs patent protection later this year and face generic competition. This includes the type 2 diabetes medications Januvia and Janumet, and Predion, a treatment that helps restore muscle function that was blocked during surgery. While…

Read More